These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
898 related items for PubMed ID: 7581095
1. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G. Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095 [Abstract] [Full Text] [Related]
2. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
3. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J, Ringdén O. Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365 [Abstract] [Full Text] [Related]
4. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T, Kojima S, Kato K. Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791 [Abstract] [Full Text] [Related]
7. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899 [Abstract] [Full Text] [Related]
8. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J. Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004 [Abstract] [Full Text] [Related]
9. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, Zander AR. Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531 [Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle. von Bueltzingsloewen A, Esperou-Bourdeau H, Souillet G, Demeocq F, Mechinaud-Lacroix F, Michel G, Sadoun A, Bernaudin F, Cornu G, Donadieu J. Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167 [Abstract] [Full Text] [Related]
11. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related]
12. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). Dini G, Boni L, Abla O, Uderzo C, Polchi P, Locatelli F, Di Bartolomeo P, Arcese W, Iori AP, Rossetti F. Bone Marrow Transplant; 1994 Jun; 13(6):771-6. PubMed ID: 7920313 [Abstract] [Full Text] [Related]
13. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300 [Abstract] [Full Text] [Related]
14. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). Deconinck E, Cahn JY, Milpied N, Jouet JP, Vernant JP, Esperou H, Lioure B, Bordigoni P, Leblond V, Troussard X, Caillot D, Cordonnier JM, Hervé P. Bone Marrow Transplant; 1997 Nov; 20(9):731-5. PubMed ID: 9384474 [Abstract] [Full Text] [Related]
15. Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients. Aschan J, Ringdén O, Andström E, Ljungman P, Lönnqvist B, Remberger M. Bone Marrow Transplant; 1994 Jul; 14(1):79-87. PubMed ID: 7951124 [Abstract] [Full Text] [Related]
16. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation. Conter V, D'Angelo P, Rizzari C, Jankovic M, Dampier C, Masera G, Johnson FL. Bone Marrow Transplant; 1996 Feb; 17(2):287-9. PubMed ID: 8640182 [Abstract] [Full Text] [Related]
17. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P. Cancer J Sci Am; 1996 Feb; 2(6):330-4. PubMed ID: 9166553 [Abstract] [Full Text] [Related]
18. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON). Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771 [Abstract] [Full Text] [Related]
19. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [Abstract] [Full Text] [Related]
20. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM. Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947 [Abstract] [Full Text] [Related] Page: [Next] [New Search]